Dry Eye Relief

Manufacturer: Similasan Corporation | International Packaging Inc
Effective date: 2018-11-14
Label type: HUMAN OTC DRUG LABEL
Version: 7
Source: full-release
Hydrated at: 2026-06-01 02:11:12

Label at a glance#

ProductDry Eye Relief

Active ingredientATROPA BELLADONNA, EUPHRASIA STRICTA, MERCURIC CHLORIDE

Label structure12 sections

Indications and uses

According to homeopathic principles, the active ingredients in this medication temporarily relieve minor symptoms such as: dry eye redness of eyes and lids reflex watering secondary to dry eye sensation of grittiness sensitivity to light

Dosage and administration

For adults and children age 2 and over: remove a single-use dropper twist flat end with ball to remove squeeze plastic dropper to release 2-3 drops into eye and discard applicator

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Belladonna* 6X

*containing 0.000002% alkaloids calculated as hyoscyamine.

Purpose

OTC - PURPOSE SECTION

dryness, redness

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Euphrasia 6X

Purpose

OTC - PURPOSE SECTION

redness

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Mercurius sublimatus 6X

Purpose

OTC - PURPOSE SECTION

dryness

Uses

INDICATIONS & USAGE SECTION

According to homeopathic principles, the active ingredients in this medication temporarily relieve minor symptoms such as:

dry eye
redness of eyes and lids
reflex watering secondary to dry eye
sensation of grittiness
sensitivity to light

Warnings

WARNINGS SECTION

For external use only.
Initial exacerbation of symptoms may occur.
Use only if single-use dropper is intact.
To avoid contamination, do not touch the tip of the dropper to any surface. Do not reuse. Once opened, discard.
Contact wearers: consult a physician prior to using.

Do not use:

OTC - DO NOT USE SECTION

if the solution changes color or becomes cloudy

Stop use and ask a doctor if:

OTC - ASK DOCTOR SECTION

symptoms worsen or persist for more than 72 hours.
changes in vision occur.
you experience eye pain.

If pregnant or breast feeding,

PREGNANCY SECTION

ask a health professional before use.

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

For adults and children age 2 and over:

remove a single-use dropper
twist flat end with ball to remove
squeeze plastic dropper to release 2-3 drops into eye and discard applicator

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Phosphate buffer, Purified water

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 59262-352-13
Similasan
Dry Eye
Relief
SINGLE-USE STERILE EYE DROPS
Preservative Free
0.4 ml/ 0.014 fl oz each
NDC 59262-352-13 Similasan Dry Eye Relief SINGLE-USE STERILE EYE DROPS Preservative Free 0.4 ml/ 0.014 fl oz each

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

SIMILASAN / USA
30011
Dry Eye Relief, eye drops
270 pieces(Stk)

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
726062af-1135-4707-a1d7-57256991bbf9	Product name	2	20250226
19c71a3d-ed9c-166b-a7e5-38c250c35631	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
59262-352-01	2021-01-29	C162847	48780-1	ba0f9c33-25f9-a910-e053-dadaa90a0b85	Similasan Dry Eye Relief Trial Size
59262-352-13	2021-01-29	C162847	48780-1	ba0f9c33-25f9-a910-e053-dadaa90a0b85	Similasan Dry Eye Relief Trial Size

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
59262-352-01	Dry Eye Relief	0.4 mL in 1 VIAL, SINGLE-USE	SOLUTION/ DROPS	0.4	7
59262-352-01	Dry Eye Relief	270 in 1 CARTON	SOLUTION/ DROPS	270	7
59262-352-13	Dry Eye Relief	.4 mL in 1 VIAL, SINGLE-USE	SOLUTION/ DROPS	.4	7

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
59262-352	DRY EYE RELIEF (ATROPA BELLADONNA AND EUPHRASIA STRICTA AND MERCURIC CHLORIDE) SOLUTION/ DROPS [SIMILASAN CORPORATION]	7	Legacy NDC, 3 package rows	20190329_556395b6-a928-44a0-929a-e7ffa2f5e358.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
ATROPA BELLADONNA	ACTIVE INGREDIENT	WQZ3G9PF0H	6
EUPHRASIA STRICTA	ACTIVE INGREDIENT	C9642I91WL	6
MERCURIC CHLORIDE	ACTIVE INGREDIENT	53GH7MZT1R	6
ATROPA BELLADONNA	ACTIVE MOIETY	WQZ3G9PF0H	6
EUPHRASIA STRICTA	ACTIVE MOIETY	C9642I91WL	6
MERCURIC CATION	ACTIVE MOIETY	ED30FJ8Y42	6
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	INACTIVE INGREDIENT	22ADO53M6F	6
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE	INACTIVE INGREDIENT	5QWK665956	6
WATER	INACTIVE INGREDIENT	059QF0KO0R	6

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

Dry Eye Relief
Atropa Belladonna and Euphrasia Stricta and Mercuric Chloride
ATROPA BELLADONNA
EUPHRASIA STRICTA
MERCURIC CHLORIDE
MERCURIC CATION
WATER
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
59262-352	59262-352-01, 59262-352-13

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
ATROPA BELLADONNA	WQZ3G9PF0H	ACTIB
EUPHRASIA STRICTA	C9642I91WL	ACTIB
MERCURIC CHLORIDE	53GH7MZT1R	ACTIB
WATER	059QF0KO0R	IACT
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE	5QWK665956	IACT
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 61 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	TROCHE / ORAL	28 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	SPRAY / NASAL		1 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	SOLUTION/ DROPS / TOPICAL	0.14 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	AEROSOL, FOAM / TOPICAL	0.09 %w/w		Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE	5QWK665956	INJECTION, SOLUTION / INTRAVENOUS		115 mg	Exact identifier — unii candidate 13 equally ranked IID candidates
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE	5QWK665956	INJECTION / INTRAMUSCULAR	12.8 mg		Exact identifier — unii candidate 13 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	INJECTION, SUSPENSION / INTRA-ARTICULAR		36 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	TABLET, EXTENDED RELEASE / ORAL		210 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	INSERT / INTRAOCULAR	0.02 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	OINTMENT / TOPICAL		1 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE	5QWK665956	GEL / TOPICAL	0.02 %w/w		Exact identifier — unii candidate 13 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	SOLUTION/ DROPS / OPHTHALMIC	1.4 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE	5QWK665956	INJECTION, SOLUTION / SUBCUTANEOUS	0.3 %w/v		Exact identifier — unii candidate 13 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR	139.2 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	INJECTION / SUBCUTANEOUS		20 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	139.2 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	INJECTION, SUSPENSION / INTRAMUSCULAR		36 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	INJECTION / INTRALESIONAL		28 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	INJECTION, SUSPENSION / INTRALESIONAL		3 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	CAPSULE, DELAYED RELEASE / ORAL		43 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	SOLUTION / INTRAVENOUS		381 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	TABLET, FOR SUSPENSION / ORAL		60 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	LIQUID / INTRAVENOUS		381 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	INJECTION, SOLUTION / INTRAVENOUS		2460 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	CAPSULE, EXTENDED RELEASE / ORAL		207 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	INJECTION / INTRAMUSCULAR		1751 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	SOLUTION / NASAL	5 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	INJECTION, SOLUTION / INTRAVESICAL	38.25 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	CREAM / TOPICAL	0.36 %w/w		Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	FILM / SUBLINGUAL		6 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	INJECTION / INTRAVENOUS		381 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE	5QWK665956	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS	1.3 mg		Exact identifier — unii candidate 13 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	SPRAY, METERED / NASAL		7 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	SYRUP / ORAL		70 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS		1751 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	TABLET / ORAL		96 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE	5QWK665956	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	1.6 mg		Exact identifier — unii candidate 13 equally ranked IID candidates
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE	5QWK665956	INJECTION / INTRAVENOUS	12.8 mg		Exact identifier — unii candidate 13 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	INJECTION, EMULSION / INTRAVENOUS	0.28 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE	5QWK665956	SOLUTION/ DROPS / OPHTHALMIC	1.15 %w/v		Exact identifier — unii candidate 13 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	LOZENGE / TRANSMUCOSAL		112 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	FILM / BUCCAL	0.35 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	SOLUTION / OPHTHALMIC	1.21 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	INJECTION, SOLUTION / SUBCUTANEOUS	0.11 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR		8 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR		1751 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	TABLET, FILM COATED / ORAL	0.01 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE	5QWK665956	INJECTION, SOLUTION / INTRATHECAL	0.01 %w/v		Exact identifier — unii candidate 13 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	SUSPENSION / ORAL		66 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	INJECTION, SUSPENSION / INTRASYNOVIAL		3 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	INJECTION, SUSPENSION / SOFT TISSUE		3 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE	5QWK665956	SUSPENSION / ORAL		140 mg	Exact identifier — unii candidate 13 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	INJECTION / INTRA-ARTICULAR		28 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	INJECTION, SOLUTION / INTRATHECAL		1 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE	5QWK665956	SOLUTION / ORAL		63 mg	Exact identifier — unii candidate 13 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	FILM, SOLUBLE / ORAL	0.05 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE	5QWK665956	SOLUTION / OPHTHALMIC		2 mg	Exact identifier — unii candidate 13 equally ranked IID candidates
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE	SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE	5QWK665956	INJECTION / SUBCUTANEOUS	0.3 %w/v		Exact identifier — unii candidate 13 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	SOLUTION / ORAL		140 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	22ADO53M6F	SUSPENSION / OPHTHALMIC	NA		Exact identifier — unii candidate 48 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
1810cfc8-666f-42d2-8783-9768b3c19801			556395b6-a928-44a0-929a-e7ffa2f5e358	2018-11-14	Warnings	Exact identifier spl id: 1810cfc8-666f-42d2-8783-9768b3c19801 spl set id: 556395b6-a928-44a0-929a-e7ffa2f5e358

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.